November 2025
Corporate | Financial | Sustainability November 10, 2025
COP30: Honduras and Suriname partner with Deutsche Bank, Symrise and other industry players to mobilize financial support for rainforest protection
High-integrity carbon credits under Article 6.2 of the Paris Agreement aim to mobilize private capital for the conservation of rainforests at a national level.
The Latin American countries Honduras and Suriname intend to issue high-integrity Rainforest Carbon Credits working together with Deutsche Bank AG, Symrise AG and further industry partners as well as the…
October 2025
Corporate | Financial October 28, 2025
Symrise Reports Third Quarter 2025 Sales
— Organic growth of 1.4% in Q3; organic growth of 2.6% in first nine months of 2025
— Acceleration of transformation
— Successful placement of €800 million bond, issued with a term of 7 years and coupon rate of 3.25%
— Updating guidance to reflect the current global demand environment:
• Moderating 2025 organic growth to 2.3%-3.3% from 3.0%-5.0%
• Reaffirming of…
September 2025
Corporate | Financial September 17, 2025
Symrise announces successful placement of €800 million bond
− Multiple oversubscription confirms investors' confidence in Symrise’s strategy and financial strength
− Issued with a term of 7 years and coupon rate of 3.25 %
Corporate | Financial September 12, 2025
Symrise Receives Inaugural Investment Grade Credit Ratings from S&P Global and Moody’s
— Agencies have issued BBB+ rating (S&P Global) and Baa1 rating (Moody’s), both with stable outlooks
— Reflects Symrise’s financial strength, operational rigor, and robust ONE Symrise strategy
July 2025
Corporate | Financial July 30, 2025
Symrise Reports First Half 2025 Results
— Organic growth of 3.1%
— EBITDA margin of 21.7%, an increase of 100 basis points year-on-year
— Identified recurring cost savings through efficiency improvements of €40m in 2025, €20m realized in H1 as part of the ONE SYM Transformation
— Seeking strategic alternatives for terpene ingredients business
— Appointed Michael Friede as Symrise Executive Board Member…
May 2025
Corporate | Financial May 20, 2025
Annual General Meeting approves dividend of €1.20, all shareholder representatives confirmed
– CEO Dr Jean-Yves Parisot presents 2024 results
– Dividend of €1.20 per share approved
– All shareholder representatives on the Supervisory Board re-elected / Michael König continues as Chairman of the Board
Corporate | Financial May 19, 2025
The United Kingdom Competition & Markets Authority (CMA) is closing investigations against Symrise
CMA Investigation 51257 – Investigation under Chapter I Competition Act 1998
The CMA announced today on its website that it is closing its investigation against Symrise on suspicion of anti-competitive agreements with competitors.
April 2025
Corporate | Financial April 29, 2025
Symrise delivers solid growth in Q1 and reaffirms outlook
— Achieved organic growth of 4.2%
— Delivered sales of €1.3 billion driven primarily by higher volumes
— Reaffirms full year 2025 guidance: Organic growth 5-7% / EBITDA margin around 21% / Business free cash flow around 14%
— Conducted strategic assessment of Chemicals Production activities
March 2025
Corporate | Financial March 27, 2025
Symrise raises dividend and confirms outlook
— Dividend proposal of € 1.20 per share (2023: € 1.10) – 15th increase in succession
— Symrise confirms targets for 2025: Organic growth of 5-7 %
— Profitability (EBITDA margin) of around 21 % expected
— Executive Board contract of Dr. Stephanie Cossmann extended ahead of schedule until January 2030
January 2025
Corporate | Financial January 30, 2025
Symrise achieves significant sales growth in 2024 with a strong increase in profitability
— Organic growth of 8.7% / Group sales increase by 5.7% to around €5 billion (2023: €4.7 billion)
— EBITDA of €1,033 million significantly above previous year's figure (2023: €903 million )
— EBITDA margin rises to 20.7% (2023: 19.1%)
— Net Income increased by 40.5% to €478 million / Earnings per Share increased to €3.42 (2023:…